BeiGene Cost Of Revenue from 2010 to 2024

BGNE Stock  USD 181.62  3.92  2.21%   
BeiGene's Cost Of Revenue is increasing over the years with slightly volatile fluctuation. Overall, Cost Of Revenue is expected to go to about 746.8 M this year. During the period from 2010 to 2024 BeiGene Cost Of Revenue annual values regression line had geometric mean of  158,090,948 and mean square error of 213551.9 T. View All Fundamentals
 
Cost Of Revenue  
First Reported
2013-12-31
Previous Quarter
138.1 M
Current Value
170.5 M
Quarterly Volatility
171.8 M
 
Yuan Drop
 
Covid
Check BeiGene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BeiGene's main balance sheet or income statement drivers, such as Depreciation And Amortization of 92.1 M, Interest Expense of 39.2 M or Selling General Administrative of 1.5 B, as well as many indicators such as Price To Sales Ratio of 0.79, Dividend Yield of 0.0 or PTB Ratio of 0.55. BeiGene financial statements analysis is a perfect complement when working with BeiGene Valuation or Volatility modules.
  
Check out the analysis of BeiGene Correlation against competitors.
For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.

Latest BeiGene's Cost Of Revenue Growth Pattern

Below is the plot of the Cost Of Revenue of BeiGene over the last few years. Cost of Revenue is found on BeiGene income statement and represents the costs associated with goods and services BeiGene provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is BeiGene's Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BeiGene's overall financial position and show how it may be relating to other accounts over time.
Cost Of Revenue10 Years Trend
Slightly volatile
   Cost Of Revenue   
       Timeline  

BeiGene Cost Of Revenue Regression Statistics

Arithmetic Mean550,376,733
Geometric Mean158,090,948
Coefficient Of Variation118.56
Mean Deviation542,330,880
Median273,992,000
Standard Deviation652,543,224
Sample Variance425812.7T
Range1.9B
R-Value0.73
Mean Square Error213551.9T
R-Squared0.53
Significance0
Slope106,657,043
Total Sum of Squares5961377.2T

BeiGene Cost Of Revenue History

2024746.8 M
2023379.9 M
20221.9 B
20211.6 B
20201.4 B
2019998.5 M
2018707.7 M

About BeiGene Financial Statements

BeiGene stakeholders use historical fundamental indicators, such as BeiGene's Cost Of Revenue, to determine how well the company is positioned to perform in the future. Although BeiGene investors may analyze each financial statement separately, they are all interrelated. For example, changes in BeiGene's assets and liabilities are reflected in the revenues and expenses on BeiGene's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in BeiGene. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue379.9 M746.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether BeiGene is a strong investment it is important to analyze BeiGene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BeiGene's future performance. For an informed investment choice regarding BeiGene Stock, refer to the following important reports:
Check out the analysis of BeiGene Correlation against competitors.
For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BeiGene. If investors know BeiGene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BeiGene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(8.19)
Revenue Per Share
225.239
Quarterly Revenue Growth
0.395
Return On Assets
(0.1)
Return On Equity
(0.23)
The market value of BeiGene is measured differently than its book value, which is the value of BeiGene that is recorded on the company's balance sheet. Investors also form their own opinion of BeiGene's value that differs from its market value or its book value, called intrinsic value, which is BeiGene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BeiGene's market value can be influenced by many factors that don't directly affect BeiGene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BeiGene's value and its price as these two are different measures arrived at by different means. Investors typically determine if BeiGene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BeiGene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.